At very high concentrations (e.g., 20 mg/mL), a 1 mg dose requires drawing only 0.05 mL (5 units on a U-100 syringe), where the precision limit of the syringe graduation introduces clinically meaningful dose error
It uses finer needles (29-31G vs
Sport and international status AOD-9604 is on the World Anti-Doping Agency Prohibited List under section S2.2
[1] According to the researchers TGF-beta1 induction of angiogenesis requires a rapid and transient apoptotic effect mediated by VEGF/VEGFR2. AHK-Cu, by enhancing levels of the Vascular Endothelial Growth Factor, may possibly activate fibroblasts and endothelial cells
Critically, because it lacks the N-terminal domain responsible for IGF-1 stimulation, AOD-9604 doesn't elevate blood glucose or increase cancer risk markers the way full-length growth hormone does
However, it is essential to use Neurobion needle formulations under the guidance of a healthcare provider to ensure proper dosage and monitoring